ロード中...
What Occurs in the Other 20% of Cancer Patients with Chemotherapy-Induced Nausea and Vomiting (CINV)? A Single-Institution Qualitative Study
PURPOSE: Despite recent advances in prophylaxis and management, 20% of patients who receive moderately to severely emetogenic chemotherapy continue to experience nausea and vomiting. Relying on patients’ own words, this study sought to capture and characterize the lived experience with chemotherapy-...
保存先:
| 出版年: | Support Care Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309746/ https://ncbi.nlm.nih.gov/pubmed/29938306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-018-4323-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|